The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARCA BIOPHARMA INC | COM | 00211Y506 | 1,406,791 | 706,930 | SH | SOLE | 0 | 0 | 706,930 | |||
| ABERCROMBIE & FITCH CO | CL A | 002896207 | 8,207,840 | 295,778 | SH | SOLE | 0 | 0 | 295,778 | |||
| ADICET BIO INC | COM | 007002108 | 172,800 | 30,000 | SH | SOLE | 0 | 0 | 30,000 | |||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 5,069,994 | 7,067,179 | SH | SOLE | 0 | 0 | 7,067,179 | |||
| ASTROTECH CORP | COM | 046484309 | 2,349,571 | 220,410 | SH | SOLE | 0 | 0 | 220,410 | |||
| ATHIRA PHARMA INC | COM | 04746L104 | 4,662,268 | 1,864,907 | SH | SOLE | 0 | 0 | 1,864,907 | |||
| LISATA THERAPEUTICS INC | COM | 128058302 | 791,258 | 243,839 | SH | SOLE | 0 | 0 | 243,839 | |||
| CARISMA THERAPEUTICS INC | COM | 14216R101 | 1,275,334 | 411,398 | SH | SOLE | 0 | 0 | 411,398 | |||
| CYTEIR THERAPEUTICS INC | COM | 23284P103 | 5,726,259 | 3,146,296 | SH | SOLE | 0 | 0 | 3,146,296 | |||
| DISC MEDICINE INC | COM | 254604101 | 4,410,932 | 208,161 | SH | SOLE | 0 | 0 | 208,161 | |||
| ELIEM THERAPEUTICS INC | COM | 28658R106 | 4,808,693 | 1,658,170 | SH | SOLE | 0 | 0 | 1,658,170 | |||
| EMBARK TECHNOLOGY INC | COM NEW | 29079J202 | 3,611,946 | 1,285,390 | SH | SOLE | 0 | 0 | 1,285,390 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 4,646,720 | 212,179 | SH | SOLE | 0 | 0 | 212,179 | |||
| FORTE BIOSCIENCES INC | COM | 34962G109 | 1,752,426 | 1,735,075 | SH | SOLE | 0 | 0 | 1,735,075 | |||
| GRAPHITE BIO INC | COM | 38870X104 | 373,113 | 152,291 | SH | SOLE | 0 | 0 | 152,291 | |||
| ISHARES TR | 0-3 MNTH TREASRY | 46436E718 | 12,572,500 | 125,000 | SH | SOLE | 0 | 0 | 125,000 | |||
| JOUNCE THERAPEUTICS INC | COM | 481116101 | 2,012,728 | 1,087,961 | SH | SOLE | 0 | 0 | 1,087,961 | |||
| METACRINE INC | COM | 59101E103 | 3,519,152 | 6,167,458 | SH | SOLE | 0 | 0 | 6,167,458 | |||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 866,800 | 220,000 | SH | SOLE | 0 | 0 | 220,000 | |||
| NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 16,624 | 23,749 | SH | SOLE | 0 | 0 | 23,749 | |||
| NEXTCURE INC | COM | 65343E108 | 453,568 | 306,465 | SH | SOLE | 0 | 0 | 306,465 | |||
| ORAMED PHARMACEUTICALS INC | COM NEW | 68403P203 | 2,955,917 | 1,355,925 | SH | SOLE | 0 | 0 | 1,355,925 | |||
| PARDES BIOSCIENCES INC | COM | 69945Q105 | 5,262,282 | 3,986,577 | SH | SOLE | 0 | 0 | 3,986,577 | |||
| PASSAGE BIO INC | COM | 702712100 | 323,192 | 337,467 | SH | SOLE | 0 | 0 | 337,467 | |||
| RETRACTABLE TECHNOLOGIES INC | COM | 76129W105 | 1,170,006 | 668,575 | SH | SOLE | 0 | 0 | 668,575 | |||
| SPDR SER TR | BLOOMBERG 1-3 MO | 78468R663 | 18,364,000 | 200,000 | SH | SOLE | 0 | 0 | 200,000 | |||
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 4,498,340 | 6,440,000 | SH | SOLE | 0 | 0 | 6,440,000 | |||
| SURROZEN INC | COM | 86889P109 | 899,410 | 1,494,037 | SH | SOLE | 0 | 0 | 1,494,037 | |||
| TALARIS THERAPEUTICS INC | COM | 87410C104 | 3,627,430 | 1,929,484 | SH | SOLE | 0 | 0 | 1,929,484 | |||
| TILLYS INC | CL A | 886885102 | 8,903,847 | 1,154,844 | SH | SOLE | 0 | 0 | 1,154,844 | |||
| VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 975,000 | 150,000 | SH | SOLE | 0 | 0 | 150,000 | |||